RANCHO CORDOVA, Calif., Nov. 7,
2018 /PRNewswire/ -- Cesca Therapeutics Inc. ("Cesca" or the
"Company") (NASDAQ: KOOL), a market leader in automated cell
processing and point-of-care, autologous cell-based therapies,
today announced that the Company will release its financial results
for the third quarter ended September 30,
2018 on Wednesday, November 14,
2018 after the close of trading. A conference call and
webcast will follow at 4:30 p.m. EST
(1:30 p.m. PST).
Participants may access the call by dialing 1-844-889-4331
within the U.S. or 1-412-380-7406 outside the U.S. and referencing
"Cesca." To access a live webcast of the call, please visit:
https://services.choruscall.com/links/kool181113.html.
A replay of the call will be available until December 4, 2018 and can be accessed by dialing
1-877-344-7529 within the U.S. or 1-412-317-0088 outside the U.S.
and referencing access code 10125285.
About Cesca Therapeutics Inc.
Cesca Therapeutics Inc.
(the "Company") develops, commercializes and markets a range of
automated technologies for CAR-T and other cell-based therapies.
Its device division, ThermoGenesis Corp., provides a full suite of
solutions for automated clinical biobanking, point-of-care
applications, and automation for immuno-oncology. The Company is
developing an automated, functionally-closed CAR-TXpress™ platform
to streamline the manufacturing process for the emerging CAR-T
immunotherapy market. For additional information, please go
to: http://www.cescatherapeutics.com.
Company Contact:
Cesca Therapeutics Inc.
Wendy Samford
916-858-5191
ir@cescatherapeutics.com
Investor Contact:
Rx Communications
Paula Schwartz
917-322-2216
pschwartz@rxir.com
View original
content:http://www.prnewswire.com/news-releases/cesca-therapeutics-to-announce-financial-results-for-the-third-quarter-ended-september-30-2018-and-host-conference-call-on-november-14-300744989.html
SOURCE Cesca Therapeutics Inc.